SG27793G - Process for the preparation of arylpiperidine carbinols - Google Patents

Process for the preparation of arylpiperidine carbinols

Info

Publication number
SG27793G
SG27793G SG277/93A SG27793A SG27793G SG 27793 G SG27793 G SG 27793G SG 277/93 A SG277/93 A SG 277/93A SG 27793 A SG27793 A SG 27793A SG 27793 G SG27793 G SG 27793G
Authority
SG
Singapore
Prior art keywords
arylpiperidine
carbinols
preparation
arylpiperidine carbinols
Prior art date
Application number
SG277/93A
Other languages
English (en)
Original Assignee
Beecham Group Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB858520153A external-priority patent/GB8520153D0/en
Priority claimed from GB868612579A external-priority patent/GB8612579D0/en
Application filed by Beecham Group Plc filed Critical Beecham Group Plc
Publication of SG27793G publication Critical patent/SG27793G/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/86—Oxygen atoms
    • C07D211/88—Oxygen atoms attached in positions 2 and 6, e.g. glutarimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, ***e
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SG277/93A 1985-08-10 1993-03-15 Process for the preparation of arylpiperidine carbinols SG27793G (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB858520153A GB8520153D0 (en) 1985-08-10 1985-08-10 Chemical process
GB868612579A GB8612579D0 (en) 1986-05-23 1986-05-23 Chemical process

Publications (1)

Publication Number Publication Date
SG27793G true SG27793G (en) 1993-05-21

Family

ID=26289644

Family Applications (1)

Application Number Title Priority Date Filing Date
SG277/93A SG27793G (en) 1985-08-10 1993-03-15 Process for the preparation of arylpiperidine carbinols

Country Status (17)

Country Link
US (1) US4902801A (de)
EP (1) EP0223334B1 (de)
JP (2) JPH0696551B2 (de)
AU (1) AU582456B2 (de)
BG (1) BG61319B2 (de)
CA (1) CA1310649C (de)
CY (1) CY1708A (de)
DE (1) DE3680184D1 (de)
DK (1) DK169730B1 (de)
ES (2) ES2000603A6 (de)
GR (1) GR862102B (de)
HK (1) HK69793A (de)
IE (1) IE58831B1 (de)
MX (1) MX171822B (de)
NZ (1) NZ217141A (de)
PT (1) PT83179B (de)
SG (1) SG27793G (de)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
DK588289D0 (da) * 1989-11-22 1989-11-22 Ferrosan As Ny heterocyklisk kemi
JPH04288059A (ja) * 1991-03-14 1992-10-13 Nippon Paint Co Ltd 複素環化合物及びその製造法
GB9209687D0 (en) * 1992-05-06 1992-06-17 Smithkline Beecham Plc Novel process
US5258517A (en) * 1992-08-06 1993-11-02 Sepracor, Inc. Method of preparing optically pure precursors of paroxetine
GB9305175D0 (en) * 1993-03-13 1993-04-28 Smithkline Beecham Plc Novel process
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US6444190B2 (en) 1995-08-03 2002-09-03 Fmc Corporation Reduction compositions and processes for making the same
WO1997005879A1 (en) * 1995-08-03 1997-02-20 Fmc Corporation Reductions using hydrides
ES2121685B1 (es) * 1996-04-10 1999-09-16 Vita Invest Sa Procedimiento para la obtencion de (+)-trans-4(4-fluoro-fenil)-3-hidroximetil-1-metilpiperidina.
JP3446468B2 (ja) 1996-04-15 2003-09-16 旭硝子株式会社 ピペリジンカルビノール類の製造方法
US5936090A (en) * 1996-05-24 1999-08-10 Fmc Corporation Processes for the reduction of imide ester functionality
EP1384711A1 (de) 1996-06-13 2004-01-28 SUMIKA FINE CHEMICALS Co., Ltd. Optische Trennung eines Piperidin-Derivates
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
WO1998013319A1 (en) * 1996-09-24 1998-04-02 Fmc Corporation Novel reduction compositions and processes for making the same
GB9623359D0 (en) * 1996-11-09 1997-01-08 Smithkline Beecham Plc Novel process
DE69840909D1 (de) * 1997-04-07 2009-07-30 Univ Georgetown Analoge von kokain
GB9710004D0 (en) * 1997-05-17 1997-07-09 Knoll Ag Chemical process
HUP0003958A3 (en) 1997-05-29 2001-06-28 Smithkline Beecham Plc Process for preparation of 4-aryl-piperidines and intermediates
AU3108097A (en) * 1997-06-10 1998-12-30 Synthon B.V. 4-phenylpiperidine compounds
EP0969002B1 (de) 1998-06-29 2003-08-27 SUMIKA FINE CHEMICALS Co., Ltd. L-Tartrate von Trans-(-)-4-(4-Fluorphenyl)-3-Hydroxymethyl-Piperidin Verbindungen und Verfahren zu ihrer Herstellung
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
WO2000026187A1 (en) * 1998-11-02 2000-05-11 Synthon B.V. Process for producing 4-arylpiperidine-3-carbinols and related compounds
GB9915303D0 (en) * 1999-06-30 1999-09-01 Smithkline Beecham Plc Novel process
IT1313702B1 (it) * 1999-08-02 2002-09-09 Chemi Spa Processo per la preparazione di derivati 3-sostituiti di 4-fenil-piperidine.
GB9920147D0 (en) * 1999-08-25 1999-10-27 Smithkline Beecham Plc Novel process
AU1037701A (en) * 1999-10-20 2001-04-30 Smithkline Beecham Plc Process for the preparation of 4-(fluorophenyl)piperidine esters
GB9924855D0 (en) * 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel processes
GB9924882D0 (en) * 1999-10-20 1999-12-22 Smithkline Beecham Plc Novel process
GB9930577D0 (en) * 1999-12-23 2000-02-16 Smithkline Beecham Plc Novel process
WO2001085688A1 (en) * 2000-05-12 2001-11-15 Synthon B.V. TOSYLATE SALTS OF 4-(p-FLUOROPHENYL)-PIPERIDINE-3-CARBINOLS
US6833458B2 (en) 2000-06-05 2004-12-21 Development Center For Biotechnology Practical syntheses of chiral trans-3, 4-disubstituted piperidines and the intermediates
WO2002028834A1 (en) * 2000-10-06 2002-04-11 Smithkline Beecham P.L.C. Process for the preparation of aryl-piperidine carbinols and intermediates thereof
WO2002053537A1 (en) * 2001-01-04 2002-07-11 Ferrer Internacional, S.A. Process for preparing (±) trans-4-p-fluorophenyl-3-hydroxymethyl-1-methylpiperidine
US6777554B2 (en) 2001-02-05 2004-08-17 Teva Pharmaceutical Industries Ltd. Preparation of N-methylparoxetine and related intermediate compounds
EP1362032A2 (de) * 2001-02-24 2003-11-19 Spurcourt Limited Verfahren zur herstellung von paroxetin und dabei verwendete zwischenprodukte
EP1406624A4 (de) * 2001-06-13 2005-03-30 Teva Pharma Verfahren zur herstellung von paroxetin, das im wesentlichen frei von alkoxyverunreinigungen ist
KR100477048B1 (ko) * 2002-07-05 2005-03-17 임광민 피페리딘 화합물의 새로운 제조방법
WO2004043921A1 (en) * 2002-11-11 2004-05-27 Natco Pharma Limited Novel process for the preparation of 4-aryl-3-hydroxymethyl-1-methylpiperidines.
US20050266082A1 (en) * 2004-05-26 2005-12-01 Patel Satishkumar A Preparation of stable paroxetine HC1 ER tablets using a melt granulation process
CN101205211B (zh) * 2006-12-19 2011-12-14 北京德众万全药物技术开发有限公司 一种盐酸帕罗西汀重要中间体的制备方法
IN2013MU03596A (de) * 2013-11-18 2015-07-24 Piramal Entpr Ltd
CN104262255A (zh) * 2014-09-22 2015-01-07 四川大学 一种不对称催化合成γ-硝基吡唑酰胺化合物的方法
CN104402800A (zh) * 2014-12-02 2015-03-11 千辉药业（安徽）有限责任公司 一种反式-4-(4-氟苯基)-3-羟甲基-1-甲基哌啶的制备方法
WO2022269643A1 (en) * 2021-06-25 2022-12-29 Vihita Chem Private Limited An improved process for the preparation of intermediate for paroxetine

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE625656A (de) * 1961-12-05
NL125654C (de) * 1963-12-17 1900-01-01
US3666746A (en) * 1969-06-25 1972-05-30 Gaf Corp Pyrrolidonylphenyl azo dyestuffs
US3681327A (en) * 1970-07-01 1972-08-01 Exxon Research Engineering Co N-methylenethiophosphate derivatives of 1,3-thiazines and 1,4-thiazanes
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
US3947460A (en) * 1974-06-27 1976-03-30 Sandoz, Inc. 5-Hydroxy-5-substituted phenyl-pyrrolidones and piperidinones
EP0047516B1 (de) * 1980-09-04 1984-01-04 Toray Industries, Inc. Propylaminderivate und Verfahren zu deren Herstellung
US4585777A (en) * 1984-02-07 1986-04-29 A/S Ferrosan (-)-Trans-4-(4-fluorophenyl)-3-(4-methoxyphenoxy)methylpiperidine for potentiating 5-HT

Also Published As

Publication number Publication date
JPH07138228A (ja) 1995-05-30
GR862102B (en) 1986-12-30
AU582456B2 (en) 1989-03-23
JPH0696551B2 (ja) 1994-11-30
IE58831B1 (en) 1993-11-17
MX171822B (es) 1993-11-17
DK380986A (da) 1987-02-11
NZ217141A (en) 1989-06-28
JPS6239566A (ja) 1987-02-20
DK169730B1 (da) 1995-01-30
ES2005745A6 (es) 1989-03-16
ES2000603A6 (es) 1988-03-01
CA1310649C (en) 1992-11-24
EP0223334A1 (de) 1987-05-27
PT83179A (en) 1986-09-01
BG61319B2 (bg) 1997-05-30
HK69793A (en) 1993-07-30
EP0223334B1 (de) 1991-07-10
DE3680184D1 (de) 1991-08-14
CY1708A (en) 1994-01-14
PT83179B (pt) 1989-03-30
DK380986D0 (da) 1986-08-08
AU6101286A (en) 1987-02-12
US4902801A (en) 1990-02-20
IE862135L (en) 1987-02-10
JPH08809B2 (ja) 1996-01-10

Similar Documents

Publication Publication Date Title
HK69793A (en) Process for the preparation of aryl-piperidine carbinols
EP0165537A3 (en) Process for the preparation of heteroaryloxyacetamides
PT79818A (en) Process for the preparation of alpha-acetylamin-ergolines
HRP921043B1 (en) Process for the preparation of hydroxy-4-2h-1-benzothiopyrane-2-ones
PT81526A (en) Process for the preparation of new homopropargylamines
EP0194144A3 (en) Process for the preparation of 2-alkyl-cyclopent-2-enones
GB2158824B (en) Process for the preparation of 2-amino-s-triazines
ZA867784B (en) Process for the preparation of phenylpropanones
GB2180237B (en) Process for the preparation of n-sulfamyl-3-(2-guanidino-thiazol-4-yl-methylthio)-propionamidine
DE3570653D1 (en) Process for the preparation of beta-aminoethylketones
PT80634A (en) Process for the preparation of naftoxazines
DE3660623D1 (en) Process for the preparation of 2-methyl-2-alkenals
GB2176479B (en) Process for the preparation of 2-bromo-a-ergocryptine
DE3660590D1 (en) Process for the preparation of 2-alkyl-cyclopentanones
DE3566249D1 (en) Process for the preparation of fluoroformiates
DE3560035D1 (en) Process for the preparation of 2-methyl-2-alkenals
EP0173202A3 (en) Process for the preparation of chloro-o-nitroanilines
EP0190994A3 (en) Process for the preparation of 1-amino-2-bromo-4-hydroxyanthraquinone
EP0175364A3 (en) Process for the preparation of alpha-beta-diaminoacrylnitriles
EP0191385A3 (en) Process for the preparation of thiocyanatomethylthiobenzothiazoles
EP0190101A3 (en) Process for the preparation of n-alkyl-anilines
EP0216205A3 (en) Process for the preparation of tertiary phosphanoxides
EP0166214A3 (en) Process for the preparation of dialkylsuccinylsuccinat
EP0218980A3 (en) Process for the preparation of tetrachlor-3-imino-isoindolin-1-one
ZA867368B (en) Process for the preparation of n-tetrathiodimorpholine